J&J’s India TB R&D Alliance – Can It Pull Off Something Special?

Johnson & Johnson’s tuberculosis R&D partnership with the Institute of Microbial Technology in India aims to develop shorter, simpler and safer TB regimens. The alliance has, at its forefront, an expert from the team that developed Sirturo (bedaquiline).

 Tuberculosis
J&J IS COLLABORATING WITH INDIA'S IMTECH FOR TB R&D • Source: Shutterstock

More from R&D

More from Scrip